Australia Insulin Delivery Market Outlook to 2033

The “Australia Insulin Delivery Outlook to 2033” is a comprehensive databook report, covering key market data on the Australia Insulin Delivery market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments:

The Australia Insulin Delivery Market report provides key information and data on:

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2025 company share data for Insulin Delivery Market.
Global corporate-level profiles of key companies operating within the Australia Insulin Delivery Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Report Scope

Australia Insulin Delivery is segmented as follows:

Insulin Pens
Insulin Pumps

Reasons to Buy

The Australia Insulin Delivery Market report helps you to develop:

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

1 Table of Contents

2 Introduction

2.1 What Is This Report About?
2.2 Insulin Delivery Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Insulin Delivery Market, Australia

3.1 Insulin Delivery Market, Australia, Revenue ($m), 2018-2033
3.1.1 Insulin Pens Market, Australia, Revenue ($m), by Segment, 2018-2033
3.1.2 Insulin Pumps Market, Australia, Revenue ($m), by Segment, 2018-2033
3.2 Insulin Delivery Market, Australia, Volume (Units), 2018-2033
3.2.1 Insulin Pens Market, Australia, Volume (Units), by Segment, 2018-2033
3.2.2 Insulin Pumps Market, Australia, Volume (Units), by Segment, 2018-2033
3.3 Insulin Delivery Market, Australia, Average Price ($), 2018-2033
3.4 Insulin Delivery Market, Australia, Company Share by Revenue ($m), 2025

4 Overview of Key Companies in Australia, Insulin Delivery Market

4.1 Novo Nordisk AS
4.1.1 Company Overview
4.2 Sanofi
4.2.1 Company Overview
4.3 Medtronic Plc
4.3.1 Company Overview
4.4 Eli Lilly and Co
4.4.1 Company Overview
4.5 Ypsomed Holding AG
4.5.1 Company Overview
4.6 F. Hoffmann-La Roche Ltd
4.6.1 Company Overview
4.7 Insulet Corp
4.7.1 Company Overview

5 Insulin Delivery Market Pipeline Products

6 Recent Developments

6.1 Financial Announcements
6.1.1 Aug 07, 2025: Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency)
6.2 Government and Public Interest
6.2.1 Sep 19, 2025: SAB BIO Highlights Data in Multiple Presentations at EASD
6.2.2 Sep 18, 2025: Sydney Excellence Awards Highlights
6.3 Product News
6.3.1 Sep 19, 2025: SAB BIO Highlights Data in Multiple Presentations at EASD

7 Appendix

7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer

List of Tables

Table 1: Insulin Delivery Market, Australia, Revenue ($m), USD Constant, 2018-2033
Table 2: Insulin Pens Market, Australia, Revenue ($m), USD Constant, 2018-2033
Table 3: Insulin Pumps Market, Australia, Revenue ($m), USD Constant, 2018-2033
Table 4: Insulin Delivery Market, Australia, Volume (Units), 2018-2033
Table 5: Insulin Pens Market, Australia, Volume (Units), 2018-2033
Table 6: Insulin Pumps Market, Australia, Volume (Units), 2018-2033
Table 7: Insulin Delivery Market, Australia, Average Price ($), 2018-2033
Table 8: Insulin Delivery Market, Australia, Company Share by Revenue ($m), 2025
Table 9: Insulin Delivery Market Pipeline Products

List of Figures

Figure 1: Insulin Delivery Market, Australia, Revenue ($m), USD Constant, 2018-2033
Figure 2: Insulin Pens Market, Australia, Revenue ($m), USD Constant, 2018-2033
Figure 3: Insulin Pumps Market, Australia, Revenue ($m), USD Constant, 2018-2033
Figure 4: Insulin Delivery Market, Australia, Volume (Units), 2018-2033
Figure 5: Insulin Pens Market, Australia, Volume (Units), 2018-2033
Figure 6: Insulin Pumps Market, Australia, Volume (Units), 2018-2033
Figure 7: Insulin Delivery Market, Australia, Company Share (%), 2025

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Novo Nordisk AS
Sanofi
Medtronic Plc
Eli Lilly and Co
Ypsomed Holding AG
F. Hoffmann-La Roche Ltd
Insulet Corp

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4369EUR$4,995USD£3,770GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€8738EUR$9,990USD£7,539GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€13107EUR$14,985USD£11,309GBP

The Australia Insulin Delivery Market report provides key information and data on:

Report Scope

Australia Insulin Delivery is segmented as follows:

Reasons to Buy

The Australia Insulin Delivery Market report helps you to develop:

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Australia Diabetes Care Devices Market Outlook to 2033 - Insulin Delivery and Glucose Monitoring

North America Insulin Delivery Market Outlook to 2033 - Insulin Pens and Insulin Pumps

Asia-Pacific Insulin Delivery Market Outlook to 2033 - Insulin Pens and Insulin Pumps

United States Insulin Delivery Market Outlook to 2033